Literature DB >> 16516551

Studies of human visual pathophysiology with visual evoked potentials.

Shozo Tobimatsu1, Gastone G Celesia.   

Abstract

Visual evoked potentials (VEPs) offer reproducible and quantitative data on the function of the visual pathways and the visual cortex. Pattern reversal VEPs to full-field stimulation are best suited to evaluate anterior visual pathways while hemi-field stimulation is most effective in the assessment of post-chiasmal function. However, visual information is processed simultaneously via multiple parallel channels and each channel constitutes a set of sequential processes. We outline the major parallel pathways of the visual system from the retina to the primary visual cortex and higher visual areas via lateral geniculate nucleus that receive visual input. There is no best method of stimulus selection, rather visual stimuli and VEPs' recording should be tailored to answer specific clinical and/or research questions. Newly developed techniques that can assess the functions of extrastriate as well as striate cortices are discussed. Finally, an algorithm of sequential steps to evaluate the various levels of visual processing is proposed and its clinical use revisited.

Entities:  

Mesh:

Year:  2006        PMID: 16516551     DOI: 10.1016/j.clinph.2006.01.004

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  32 in total

1.  Evidence for metaplasticity in the human visual cortex.

Authors:  Tommaso Bocci; Matteo Caleo; Silvia Tognazzi; Nikita Francini; Lucia Briscese; Lamberto Maffei; Simone Rossi; Alberto Priori; Ferdinando Sartucci
Journal:  J Neural Transm (Vienna)       Date:  2013-10-27       Impact factor: 3.575

2.  Optic nerve potentials and cortical potentials after stimulation of the anterior visual pathway during neurosurgery.

Authors:  Mitja Benedičič; Roman Bošnjak
Journal:  Doc Ophthalmol       Date:  2011-03-16       Impact factor: 2.379

3.  Impaired visual cortical plasticity in schizophrenia.

Authors:  Idil Cavuş; Robert M G Reinhart; Brian J Roach; Ralitza Gueorguieva; Timothy J Teyler; Wesley C Clapp; Judith M Ford; John H Krystal; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2012-03-15       Impact factor: 13.382

4.  Spatial frequency differentially affects habituation in migraineurs: a steady-state visual-evoked potential study.

Authors:  Koichi Shibata; Kiyomi Yamane; Yoshiko Nishimura; Hiromi Kondo; Kuniaki Otuka
Journal:  Doc Ophthalmol       Date:  2011-07-19       Impact factor: 2.379

Review 5.  Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children.

Authors:  C Van Mierlo; W Spileers; E Legius; I Casteels; C Cassiman
Journal:  Doc Ophthalmol       Date:  2013-07-25       Impact factor: 2.379

6.  Gender-based normative values for pattern-reversal and flash visually evoked potentials under binocular and monocular stimulation in healthy adults.

Authors:  Patrícia de Freitas Dotto; Adriana Berezovsky; Paula Yuri Sacai; Daniel Martins Rocha; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2017-05-30       Impact factor: 2.379

7.  Visual evoked potentials in patients with pineal gland cyst.

Authors:  Jelena Bosnjak; Ivan Mikula; Snjezana Miskov; Mislav Budisic; Goran Ivkic; Vida Demarin
Journal:  Wien Klin Wochenschr       Date:  2012-08-07       Impact factor: 1.704

8.  Mapping the bilateral visual integration by EEG and fMRI.

Authors:  Zhongming Liu; Nanyin Zhang; Wei Chen; Bin He
Journal:  Neuroimage       Date:  2009-03-20       Impact factor: 6.556

9.  Inattentional Deafness: Visual Load Leads to Time-Specific Suppression of Auditory Evoked Responses.

Authors:  Katharine Molloy; Timothy D Griffiths; Maria Chait; Nilli Lavie
Journal:  J Neurosci       Date:  2015-12-09       Impact factor: 6.167

10.  Effect of biological factors on latency of pattern-reversal visual evoked potentials associated with cathode ray tubes and liquid crystal display monitors in normal young subjects.

Authors:  Midori Ura; Mutsuki Matsuo; Haruna Yamazaki; Hiroshi Morita
Journal:  Doc Ophthalmol       Date:  2021-04-13       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.